Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors.

Stein, Anthony S; Schiller, Gary; Benjamin, Ramsis; Jia, Catherine; Zhang, Alicia; Zhu, Min; Zimmerman, Zachary; Topp, Max S.
Ann Hematol; 2018 Sep 20.
Artigo em Inglês | MEDLINE | ID: mdl-30238148

Não foram localizados documentos relacionados